| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |